+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Dengue Testing Market Report by Test Type (ELISA-based Tests, RT-PCR based Tests, Dengue IgG/IgM Rapid Test, and Others), End User (Hospitals, Diagnostic Centers, and Others), and Region 2024-2032

  • PDF Icon

    Report

  • 149 Pages
  • July 2024
  • Region: Global
  • IMARC Group
  • ID: 5615111
The global dengue testing market size reached US$ 584.2 Million in 2023. Looking forward, the publisher expects the market to reach US$ 879.0 Million by 2032, exhibiting a growth rate (CAGR) of 4.6% during 2023-2032.

Dengue, also known as breakbone fever, is a viral infection that spreads through the bite of an infected Aedes aegypti mosquito. It causes ache in the joints and muscles, high fever, abdominal pain, vomiting, difficulty in breathing, clammy and cold skin, headache, pain behind the eyes, fatigue, rashes, and mild bleeding in the nose and gums. It is diagnosed via dengue testing, which includes enzyme-linked immunosorbent assay (ELISA), RT-PCR, and dengue IgG/IgM rapid tests. Dengue testing is performed by medical professionals using a blood sample to identify the different serotypes of the dengue virus.

Dengue Testing Market Trends:

The growing cases of dengue on account of the rising global warming and breeding sites of mosquitos across the globe represents one of the major factors driving the market. Moreover, accurate and efficient diagnosis of dengue plays a pivotal role in clinical care. It assists in pathogenesis, clinical trials, outbreak control, academic research, vaccine development, surveillance activities, early detection of severe cases, and case confirmation and differential diagnosis with other infectious diseases. These benefits are positively influencing the demand for dengue testing around the world. Besides this, densely populated areas worldwide are more disease-prone due to low living conditions. This, along with poor sanitation and waste management techniques due to lack of public awareness, is stimulating the growth of the market. In addition, healthcare professionals are encouraging people to prevent dengue by self-protection and thermal fogging of insecticides. This, coupled with awareness campaigns organized by the government of several countries, is propelling the growth of the market. Other growth-inducing factors are rapid urbanization and technological advancements in the healthcare industry. Furthermore, key market players are extensively investing in research and development (R&D) activities to develop highly efficient and cost-effective dengue test kits.

Key Market Segmentation:

The report provides an analysis of the key trends in each sub-segment of the global dengue testing market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on test type and end user.

Breakup by Test Type:

ELISA-based Tests
RT-PCR based Tests
Dengue IgG/IgM Rapid Test
Others

Breakup by End User:

Hospitals
Diagnostic Centers
Others

Breakup by Region:

North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Abnova Corporation, CerTest Biotec S.L., DiaSorin S.p.A., F. Hoffmann-La Roche AG, InBios International Inc., NovaTec Immundiagnostica GmbH, OriGene Technologies Inc., PerkinElmer Inc., Quest Diagnostics Incorporated and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report

1. How big is the global dengue testing market?
2. What is the expected growth rate of the global dengue testing market during 2024-2032?
3. What are the key factors driving the global dengue testing market?
4. What has been the impact of COVID-19 on the global dengue testing market?
5. What is the breakup of the global dengue testing market based on the test type?
6. What is the breakup of the global dengue testing market based on the end user?
7. What are the key regions in the global dengue testing market?
8. Who are the key players/companies in the global dengue testing market?

Table of Contents

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Dengue Testing Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Test Type
6.1 ELISA-based Tests
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 RT-PCR based Tests
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Dengue IgG/IgM Rapid Test
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Others
6.4.1 Market Trends
6.4.2 Market Forecast
7 Market Breakup by End User
7.1 Hospitals
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Diagnostic Centers
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Others
7.3.1 Market Trends
7.3.2 Market Forecast
8 Market Breakup by Region
8.1 North America
8.1.1 United States
8.1.1.1 Market Trends
8.1.1.2 Market Forecast
8.1.2 Canada
8.1.2.1 Market Trends
8.1.2.2 Market Forecast
8.2 Asia-Pacific
8.2.1 China
8.2.1.1 Market Trends
8.2.1.2 Market Forecast
8.2.2 Japan
8.2.2.1 Market Trends
8.2.2.2 Market Forecast
8.2.3 India
8.2.3.1 Market Trends
8.2.3.2 Market Forecast
8.2.4 South Korea
8.2.4.1 Market Trends
8.2.4.2 Market Forecast
8.2.5 Australia
8.2.5.1 Market Trends
8.2.5.2 Market Forecast
8.2.6 Indonesia
8.2.6.1 Market Trends
8.2.6.2 Market Forecast
8.2.7 Others
8.2.7.1 Market Trends
8.2.7.2 Market Forecast
8.3 Europe
8.3.1 Germany
8.3.1.1 Market Trends
8.3.1.2 Market Forecast
8.3.2 France
8.3.2.1 Market Trends
8.3.2.2 Market Forecast
8.3.3 United Kingdom
8.3.3.1 Market Trends
8.3.3.2 Market Forecast
8.3.4 Italy
8.3.4.1 Market Trends
8.3.4.2 Market Forecast
8.3.5 Spain
8.3.5.1 Market Trends
8.3.5.2 Market Forecast
8.3.6 Russia
8.3.6.1 Market Trends
8.3.6.2 Market Forecast
8.3.7 Others
8.3.7.1 Market Trends
8.3.7.2 Market Forecast
8.4 Latin America
8.4.1 Brazil
8.4.1.1 Market Trends
8.4.1.2 Market Forecast
8.4.2 Mexico
8.4.2.1 Market Trends
8.4.2.2 Market Forecast
8.4.3 Others
8.4.3.1 Market Trends
8.4.3.2 Market Forecast
8.5 Middle East and Africa
8.5.1 Market Trends
8.5.2 Market Breakup by Country
8.5.3 Market Forecast
9 SWOT Analysis
9.1 Overview
9.2 Strengths
9.3 Weaknesses
9.4 Opportunities
9.5 Threats
10 Value Chain Analysis
11 Porters Five Forces Analysis
11.1 Overview
11.2 Bargaining Power of Buyers
11.3 Bargaining Power of Suppliers
11.4 Degree of Competition
11.5 Threat of New Entrants
11.6 Threat of Substitutes
12 Price Analysis
13 Competitive Landscape
13.1 Market Structure
13.2 Key Players
13.3 Profiles of Key Players
13.3.1 Abbott Laboratories
13.3.1.1 Company Overview
13.3.1.2 Product Portfolio
13.3.1.3 Financials
13.3.1.4 SWOT Analysis
13.3.2 Abnova Corporation
13.3.2.1 Company Overview
13.3.2.2 Product Portfolio
13.3.2.3 Financials
13.3.3 CerTest Biotec S.L.
13.3.3.1 Company Overview
13.3.3.2 Product Portfolio
13.3.4 DiaSorin S.p.A.
13.3.4.1 Company Overview
13.3.4.2 Product Portfolio
13.3.4.3 Financials
13.3.4.4 SWOT Analysis
13.3.5 F. Hoffmann-La Roche AG
13.3.5.1 Company Overview
13.3.5.2 Product Portfolio
13.3.5.3 Financials
13.3.6 InBios International Inc.
13.3.6.1 Company Overview
13.3.6.2 Product Portfolio
13.3.7 NovaTec Immundiagnostica GmbH
13.3.7.1 Company Overview
13.3.7.2 Product Portfolio
13.3.8 OriGene Technologies Inc.
13.3.8.1 Company Overview
13.3.8.2 Product Portfolio
13.3.9 PerkinElmer Inc.
13.3.9.1 Company Overview
13.3.9.2 Product Portfolio
13.3.9.3 Financials
13.3.9.4 SWOT Analysis
13.3.10 Quest Diagnostics Incorporated
13.3.10.1 Company Overview
13.3.10.2 Product Portfolio
13.3.10.3 Financials
13.3.10.4 SWOT Analysis
13.3.11 Thermo Fisher Scientific Inc.
13.3.11.1 Company Overview
13.3.11.2 Product Portfolio
13.3.11.3 Financials
13.3.11.4 SWOT Analysis
List of Figures
Figure 1: Global: Dengue Testing Market: Major Drivers and Challenges
Figure 2: Global: Dengue Testing Market: Sales Value (in Million US$), 2018-2023
Figure 3: Global: Dengue Testing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 4: Global: Dengue Testing Market: Breakup by Test Type (in %), 2023
Figure 5: Global: Dengue Testing Market: Breakup by End User (in %), 2023
Figure 6: Global: Dengue Testing Market: Breakup by Region (in %), 2023
Figure 7: Global: Dengue Testing (ELISA-based Tests) Market: Sales Value (in Million US$), 2018 & 2023
Figure 8: Global: Dengue Testing (ELISA-based Tests) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 9: Global: Dengue Testing (RT-PCR based Tests) Market: Sales Value (in Million US$), 2018 & 2023
Figure 10: Global: Dengue Testing (RT-PCR based Tests) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 11: Global: Dengue Testing (Dengue IgG/IgM Rapid Test) Market: Sales Value (in Million US$), 2018 & 2023
Figure 12: Global: Dengue Testing (Dengue IgG/IgM Rapid Test) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 13: Global: Dengue Testing (Other Test Types) Market: Sales Value (in Million US$), 2018 & 2023
Figure 14: Global: Dengue Testing (Other Test Types) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 15: Global: Dengue Testing (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
Figure 16: Global: Dengue Testing (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 17: Global: Dengue Testing (Diagnostic Centers) Market: Sales Value (in Million US$), 2018 & 2023
Figure 18: Global: Dengue Testing (Diagnostic Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 19: Global: Dengue Testing (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
Figure 20: Global: Dengue Testing (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 21: North America: Dengue Testing Market: Sales Value (in Million US$), 2018 & 2023
Figure 22: North America: Dengue Testing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 23: United States: Dengue Testing Market: Sales Value (in Million US$), 2018 & 2023
Figure 24: United States: Dengue Testing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 25: Canada: Dengue Testing Market: Sales Value (in Million US$), 2018 & 2023
Figure 26: Canada: Dengue Testing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 27: Asia-Pacific: Dengue Testing Market: Sales Value (in Million US$), 2018 & 2023
Figure 28: Asia-Pacific: Dengue Testing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 29: China: Dengue Testing Market: Sales Value (in Million US$), 2018 & 2023
Figure 30: China: Dengue Testing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 31: Japan: Dengue Testing Market: Sales Value (in Million US$), 2018 & 2023
Figure 32: Japan: Dengue Testing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 33: India: Dengue Testing Market: Sales Value (in Million US$), 2018 & 2023
Figure 34: India: Dengue Testing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 35: South Korea: Dengue Testing Market: Sales Value (in Million US$), 2018 & 2023
Figure 36: South Korea: Dengue Testing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 37: Australia: Dengue Testing Market: Sales Value (in Million US$), 2018 & 2023
Figure 38: Australia: Dengue Testing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 39: Indonesia: Dengue Testing Market: Sales Value (in Million US$), 2018 & 2023
Figure 40: Indonesia: Dengue Testing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 41: Others: Dengue Testing Market: Sales Value (in Million US$), 2018 & 2023
Figure 42: Others: Dengue Testing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 43: Europe: Dengue Testing Market: Sales Value (in Million US$), 2018 & 2023
Figure 44: Europe: Dengue Testing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 45: Germany: Dengue Testing Market: Sales Value (in Million US$), 2018 & 2023
Figure 46: Germany: Dengue Testing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 47: France: Dengue Testing Market: Sales Value (in Million US$), 2018 & 2023
Figure 48: France: Dengue Testing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 49: United Kingdom: Dengue Testing Market: Sales Value (in Million US$), 2018 & 2023
Figure 50: United Kingdom: Dengue Testing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 51: Italy: Dengue Testing Market: Sales Value (in Million US$), 2018 & 2023
Figure 52: Italy: Dengue Testing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 53: Spain: Dengue Testing Market: Sales Value (in Million US$), 2018 & 2023
Figure 54: Spain: Dengue Testing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 55: Russia: Dengue Testing Market: Sales Value (in Million US$), 2018 & 2023
Figure 56: Russia: Dengue Testing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 57: Others: Dengue Testing Market: Sales Value (in Million US$), 2018 & 2023
Figure 58: Others: Dengue Testing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 59: Latin America: Dengue Testing Market: Sales Value (in Million US$), 2018 & 2023
Figure 60: Latin America: Dengue Testing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 61: Brazil: Dengue Testing Market: Sales Value (in Million US$), 2018 & 2023
Figure 62: Brazil: Dengue Testing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 63: Mexico: Dengue Testing Market: Sales Value (in Million US$), 2018 & 2023
Figure 64: Mexico: Dengue Testing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 65: Others: Dengue Testing Market: Sales Value (in Million US$), 2018 & 2023
Figure 66: Others: Dengue Testing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 67: Middle East and Africa: Dengue Testing Market: Sales Value (in Million US$), 2018 & 2023
Figure 68: Middle East and Africa: Dengue Testing Market: Breakup by Country (in %), 2023
Figure 69: Middle East and Africa: Dengue Testing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 70: Global: Dengue Testing Industry: SWOT Analysis
Figure 71: Global: Dengue Testing Industry: Value Chain Analysis
Figure 72: Global: Dengue Testing Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Dengue Testing Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Dengue Testing Market Forecast: Breakup by Test Type (in Million US$), 2024-2032
Table 3: Global: Dengue Testing Market Forecast: Breakup by End User (in Million US$), 2024-2032
Table 4: Global: Dengue Testing Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 5: Global: Dengue Testing Market: Competitive Structure
Table 6: Global: Dengue Testing Market: Key Players

Companies Mentioned

  • Abbott Laboratories
  • Abnova Corporation
  • CerTest Biotec S.L.
  • DiaSorin S.p.A.
  • F. Hoffmann-La Roche AG
  • InBios International Inc.
  • NovaTec Immundiagnostica GmbH
  • OriGene Technologies Inc.
  • PerkinElmer Inc.
  • Quest Diagnostics Incorporated
  • Thermo Fisher Scientific Inc.

Methodology

Loading
LOADING...

Table Information